ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
US Tech 100
20,266.40
0.33%
Dow Jones
44,296.51
0.97%
Brent Oil
74.65
0.00%
Bitcoin
98,464.08
-0.57%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Vaxxinity Inc (VAXX) Quote

Vaxxinity Inc

Vaxxinity Inc (VAXX)

Vaxxinity Inc (CE)
0.1111
0.00
(0.00%)
Closed November 23 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.1111
Bid
0.1068
Ask
0.107
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
14.082M
Previous Close
0.1111
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
126,747,684
Dividend Yield
-
PE Ratio
-0.24
Earnings Per Share (EPS)
-0.45
Revenue
-
Net Profit
-56.93M

About Vaxxinity Inc

Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particul... Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
vaxxinity.com
Headquarters
Wilmington, Delaware, USA
Founded
-

Ask ADVFN Intelligence (AI)

VAXX Latest News

More News

Vaxxinity UB-312 Parkinson’s Trial Results Published in Nature Medicine

UB-312 is the first Parkinson's candidate to reduce pathology as measured by a seed amplification assay, and suggest clinical improvement on motor experiences of daily living. Data demonstrates...

June 20 2024
GlobeNewswire Inc.

Form 15-12G - Securities registration termination [Section 12(g)]

May 09 2024
Edgar (US Regulatory)

Form DEF 14C - Other definitive information statements

May 09 2024
Edgar (US Regulatory)

Vaxxinity Issues Shareholder Letter

CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of...

April 19 2024
GlobeNewswire Inc.

Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock

CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of...

April 19 2024
GlobeNewswire Inc.

Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting

CAPE CANAVERAL, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced it will present...

March 28 2024
GlobeNewswire Inc.

Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates

CAPE CANAVERAL, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported...

March 27 2024
GlobeNewswire Inc.

Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024

LISBON, Portugal, March 07, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (NASDAQ: VAXX), a U.S. company pioneering the development of a new class of medicines, announced positive clinical data from...

March 07 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 15 2024
Edgar (US Regulatory)

Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published

Preclinical data published in the Journal of Lipid Research indicate VXX-401 is well-tolerated, with no safety signals observed, and robustly reduces LDL-C in cynomolgus monkeys. A Phase 1 trial...

February 15 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PDYNPalladyne AI Corporation
$ 4.59
(129.50%)
83M
QMCOQuantum Corporation
$ 9.11
(126.62%)
39.41M
NANano Labs Ltd
$ 8.26
(89.02%)
2.03M
XCURExicure Inc
$ 18.60
(71.27%)
4.36M
SKKSKK Holdings Limited
$ 1.75
(59.09%)
95.06M
AMIXAutonomix Medical Inc
$ 6.21
(-54.07%)
897.51k
CETXCemtrex Inc
$ 0.1146
(-41.74%)
22.89M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
$ 3.09
(-26.25%)
305.85k
ENSCEnsysce Biosciences Inc
$ 0.4414
(-25.49%)
3.93M
ELABElevai Labs Inc
$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
$ 8.24
(18.05%)
107.91M

VAXX Discussion

View Posts
PonkenPlonken PonkenPlonken 5 months ago
i feel sorry for Mei Mei and the team. The timing of the IPO and the small cap biotech bearmarket hurt them badly. Wrong place wrong time.
Lets see, i dont think you can hold Mei Mei down.
👍️ 1
TrendTrade2016 TrendTrade2016 5 months ago
VAXX monster move
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
Delist play
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
VAXX blowing up
👍️0
glenn1919 glenn1919 6 months ago
VAXX................................https://stockcharts.com/h-sc/ui?s=VAXX&p=W&b=5&g=0&id=p86431144783
👍️0
Renee Renee 7 months ago
VAXX delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions
👍️0
stock1ace1 stock1ace1 7 months ago
Why? Delisting ..
👍️0
Triple nickle Triple nickle 7 months ago
Load em up
👍️ 1
Awl416 Awl416 7 months ago
No clue why
👍️0
Awl416 Awl416 7 months ago
Pop
👍️0
Tom turtles Tom turtles 7 months ago
Lol...bye bye VAXX...good riddance
👍️0
Awl416 Awl416 7 months ago
Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
👍️0
Awl416 Awl416 9 months ago
Vaxxinity Announces Positive Target Engagement Data from Phase 1 Clinical Trial for Parkinson’s Disease at AD/PD™ 2024
👍️0
81vette 81vette 9 months ago
not off hand,look on fda site,let us know,thanks!!!
👍️0
Monroe1 Monroe1 9 months ago
Any idea when the Phase 3 trial should finish?
👍️0
Monksdream Monksdream 10 months ago
VAXX new 52 week low
👍️0
Monksdream Monksdream 1 year ago
VAXX under $2
👍️0
Monksdream Monksdream 1 year ago
VAXX new 52 week low
👍️0
Monksdream Monksdream 1 year ago
VAXX new 52 week low
👍️0
Monksdream Monksdream 1 year ago
VAXX under $2
👍️0
81vette 81vette 2 years ago
new and effective covid booster news coming is the thought,15 days of charting up and institutions loading while crickets are chirping
👍️0
81vette 81vette 2 years ago
https://ih.advfn.com/stock-market/NASDAQ/vaxxinity-VAXX/stock-news/89692734/vaxxinity-announces-positive-topline-pivotal-phase
👍️0
81vette 81vette 2 years ago
10Xs ave vol,blowing up scanners on this low float
👍️0
81vette 81vette 2 years ago
1M short ,squeeze babe !!! could be big news enroute with institutional buying like this
👍️0
81vette 81vette 2 years ago
biggest ever institution loading> Bank Of America 3.22 mm +3.20 mm +20179.3%
Vanguard 1.53 mm +1.48 mm +2676.7%
Marshall Wace 620.46 k +620.46 k NEW
Element Capital Management 376.89 k +376.89 k NEW
Creative Planning 277.52 k +277.52 k NEW
Renaissance Technologies 262.40 k +262.40 k NEW
Millennium Management 213.62 k +213.62 k NEW
Prime Movers Lab 17.85 mm -179.00 k -1.0%
Two Sigma Investments 128.52 k +128.52 k NEW
Ghisallo Capital Management 100.00 k +100.00 k NEW
👍️0
81vette 81vette 2 years ago
3Xs ave vol.,no news,dbl bottom,47% insider owned
👍️0
bandit007 bandit007 2 years ago
Loaded the crap out of this today
👍️0
bandit007 bandit007 2 years ago
Sexy looking bottom chart. Starting to move up now. $VAXX
👍️0
bandit007 bandit007 2 years ago
Stop losses below 3 got taken out. Should start moving up now
👍️0
bandit007 bandit007 2 years ago
Took a few down here
👍️0
TheFinalCD TheFinalCD 2 years ago
and on low volume
👍️0
bandit007 bandit007 2 years ago
Got vaxx? :)
👍️0
bandit007 bandit007 2 years ago
Breaking out
👍️0
bandit007 bandit007 2 years ago
On watch again
👍️0
bandit007 bandit007 3 years ago
I only hold a small position speculating here. Could be either gold or fool’s gold. Could pay off well if it ends up being the real deal. GL
👍️0
Deano361 Deano361 3 years ago
Trading nicely today now and not spikey
👍️0
Deano361 Deano361 3 years ago
I'm in this one now. Can't figure out if real or not. Some guy on Twits board claims it's a Nancy Pelosi fraud lol! I have no idea but if they truly figure out a Alz vaccine this will be like Moderna in the 100s
👍️0
bandit007 bandit007 3 years ago
Nice bounce back from the morning dip. $VAXX
👍️0
bandit007 bandit007 3 years ago
VAXX hod close?
👍️0
crudeoil24 crudeoil24 3 years ago
Nice trade! Maybe some news coming next week.
👍️0
TheFinalCD TheFinalCD 3 years ago
5.74 vol HALT down

only P1 news

I learned from crude to be careful with P1's I got burned on one that I lost $80,000

#HardLesson
👍️0
Awl416 Awl416 3 years ago
Impressive
👍️0
TheFinalCD TheFinalCD 3 years ago
GOT VAXX?
👍️0
crudeoil24 crudeoil24 3 years ago
VAXX halted > Nasdaq circuit breaker.

👍️0
crudeoil24 crudeoil24 3 years ago
Vaxxinity Shares Surge More Than 40% in Trading Debut After IPO VAXX
12:02 pm ET November 11, 2021 (Dow Jones)
👍️0
crudeoil24 crudeoil24 3 years ago
Vaxxinity, Inc. is a biotechnology company. The Company’s synthetic peptide vaccine platform (Vaxxine Platform) enables a new class of therapeutics that will improve the access to treatments for a range of indications. Its Vaxxine Platform is designed to connect the immune system to convert the body into its own drug factory, stimulating the production of antibodies with a therapeutic or protective effect. Its technology uses synthetic peptides to mimic and optimally combine biological epitopes in order to selectively activate the immune system, producing antibodies against only the desired targets, including self-antigens, making possible the safe and effective treatment of chronic diseases by vaccines. The modular and synthetic nature of its Vaxxine Platform provides significant in candidate development and has generated multiple product candidates that it is designing for many chronic diseases.
👍️0

Your Recent History

NASDAQ
VAXX
Vaxxinity
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved